Ouzounian Maral, Lafreniere-Roula Myriam, Elbatarny Malak, David Carolyn M, Chung Jennifer C Y, David Tirone E
Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
J Thorac Cardiovasc Surg. 2025 Mar;169(3):890-895. doi: 10.1016/j.jtcvs.2024.02.023. Epub 2024 Mar 6.
To examine the late outcomes of valve-sparing root replacement and concomitant mitral valve repair in patients who have been followed prospectively for more than 2 decades.
From 1992 to 2020, 54 consecutive patients (mean age, 47 ± 16 years; 80% men) underwent valve-sparing root replacement (45 reimplantation and 9 remodeling) with concomitant repair of the mitral valve. Patients were followed prospectively for a median of 9 years (IQR, 3-14 years).
No patient experienced perioperative death or stroke. There were 3 late deaths and the 15-year overall survival was 96.0% (95% CI, 74.8%-99.4%), similar to the age- and sex-matched population. Over the follow-up period, 6 patients had reoperation of the aortic valve and 3 on the mitral valve. Of those, 2 had reoperation on both aortic and mitral valves for a total of 7 reoperations in this cohort. The cumulative proportion of reoperation at 10 years of either or both valves were as follows: aortic valve 11.4% (95% CI, 3.9%-33.3%), mitral valve 4.2% (95% CI, 0.6%-28.4%), and both valves 11.4% (95% CI, 3.9%-33.3%). The estimated probability of developing moderate/severe aortic insufficiency at 15 years was 18.5% (95% CI, 9.0%-34.2%). On final echocardiographic follow-up, none of the patients had developed moderate/severe mitral regurgitation.
In this single-center series of concomitant valve-sparing root replacement and mitral valve repair, we observed excellent clinical outcomes with a low risk of death or valve-related complications. Continued surveillance of late valve function is necessary.
研究接受保留瓣膜根部置换术及同期二尖瓣修复术且前瞻性随访超过20年的患者的远期结局。
1992年至2020年,54例连续患者(平均年龄47±16岁;80%为男性)接受保留瓣膜根部置换术(45例再植入术和9例重塑术)并同期修复二尖瓣。对患者进行前瞻性随访,中位随访时间为9年(四分位间距,3 - 14年)。
无患者发生围手术期死亡或卒中。有3例晚期死亡,15年总生存率为96.0%(95%置信区间,74.8% - 99.4%),与年龄和性别匹配的人群相似。在随访期间,6例患者接受了主动脉瓣再次手术,3例接受了二尖瓣再次手术。其中,2例患者同时接受了主动脉瓣和二尖瓣再次手术,该队列共进行了7次再次手术。10年时单瓣膜或双瓣膜再次手术的累积比例如下:主动脉瓣11.4%(95%置信区间,3.9% - 33.3%),二尖瓣4.2%(95%置信区间,0.6% - 28.4%),双瓣膜11.4%(95%置信区间,3.9% - 33.3%)。15年时发生中度/重度主动脉瓣关闭不全的估计概率为18.5%(95%置信区间,9.0% - 34.2%)。在最后一次超声心动图随访时,无患者发生中度/重度二尖瓣反流。
在这个单中心系列的保留瓣膜根部置换术及同期二尖瓣修复术中,我们观察到了良好的临床结局,死亡或瓣膜相关并发症风险较低。有必要持续监测瓣膜的远期功能。